Rib-X Pharmaceuticals IPO Pricing

The deal is expected to come on May 9th and is underwritten by Deutsche Bank Securities, William Blair, Lazard Capital Markets and Needham. The offering will give Rib-X a market cap of $204 million and the company hopes to raise $75 million from the sale. Rib-X Pharmaceuticals (RIBX) is pricing 10 million shares at $…Read more about RIB-X Pharmaceuticals here..